Penny Stock Wellgistics Health Ends Silverback Deal, Cuts Dilution Risk

Benzinga_recent_news04-11

Wellgistics Health is a healthcare technology and pharmaceutical logistics company. The company, in an SEC filing, confirmed that it delivered written notice on April 3, formally ending the agreement ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2626211261?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/10/Woman-Hand-Holding-Healthcare-Medical-Ic.jpeg?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2026-04-11 01:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2626211261","market":"hk","top_or_hot":-1,"title":"Penny Stock Wellgistics Health Ends Silverback Deal, Cuts Dilution Risk","media":"Benzinga_recent_news","content":"<div>\n<p>Wellgistics Health is a healthcare technology and pharmaceutical logistics company.\nThe company, in an SEC filing, confirmed that it delivered written notice on April 3, formally ending the agreement ...</p>\n\n<a href=\"https://www.benzinga.com/news/health-care/26/04/51761290/penny-stock-wellgistics-health-ends-silverback-deal-cuts-dilution-risk\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Penny Stock Wellgistics Health Ends Silverback Deal, Cuts Dilution Risk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPenny Stock Wellgistics Health Ends Silverback Deal, Cuts Dilution Risk\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-11 01:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/health-care/26/04/51761290/penny-stock-wellgistics-health-ends-silverback-deal-cuts-dilution-risk><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Wellgistics Health is a healthcare technology and pharmaceutical logistics company.\nThe company, in an SEC filing, confirmed that it delivered written notice on April 3, formally ending the agreement ...</p>\n\n<a href=\"https://www.benzinga.com/news/health-care/26/04/51761290/penny-stock-wellgistics-health-ends-silverback-deal-cuts-dilution-risk\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"WGRX","symbol_name":"Wellgistics Health Inc.","start_time":0,"source_url":"https://www.benzinga.com/news/health-care/26/04/51761290/penny-stock-wellgistics-health-ends-silverback-deal-cuts-dilution-risk","article_id":"2626211261","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/10/Woman-Hand-Holding-Healthcare-Medical-Ic.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/04/51761290/penny-stock-wellgistics-health-ends-silverback-deal-cuts-dilution-risk","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2626211261","pubTimestamp":1775843820,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Wellgistics Health Ends Silverback Deal, Avoids Dilution, Evaluates Neuritek Acquisition To Expand Pharma Logistics And AI-Driven Services","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"WGRX":"Wellgistics Health Inc.","BK4175":"保健护理产品经销商"},"translate_title":"细价股Wellgistics Health终止Silverback交易，降低稀释风险","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WGRX":1.5},"content_text":"Wellgistics Health is a healthcare technology and pharmaceutical logistics company.\nThe company, in an SEC filing, confirmed that it delivered written notice on April 3, formally ending the agreement dated January 28, 2026.\nBefore the termination took effect, Wellgistics had already issued 6.866 million shares as part of the agreement.\nWith the termination finalized, the settlement is no longer in force, and the company will not issue any additional shares under the structure or related regulatory provisions.\nAs part of the wind-down, Silverback Capital has been asked to return all rights, title, and interest tied to any unpaid claims to the relevant creditors.\nBoth parties have confirmed that no further obligations remain under the terminated agreement, effectively closing out the arrangement.\nIn March, the pharmaceutical distributor entered into a non-exclusive, non-binding Letter of Intent to evaluate a potential acquisition of Neuritek Therapeutics.\nThe move aims to enhance Wellgistics’ capabilities in its technology-enabled pharmacy distribution and services business.\nThe company proposed an all-stock acquisition of Neuritek Therapeutics.\nPotential Benefits include improved pipeline visibility and incremental revenue opportunities.\nThe proposed acquisition of Neuritek Therapeutics by Wellgistics Health could significantly bolster its integrated ecosystem, which spans prescription fulfillment and AI-driven patient access solutions.\nNeuritek, known for its next-generation treatment for PTSD, aligns with Wellgistics’ strategic goal of enhancing pharmaceutical partnerships and driving long-term shareholder value.\nNeuritek Therapeutics has developed a mechanism-based treatment for PTSD.\nWhile Wellgistics is focused on capturing a significant share of the healthcare market through strategic manufacturer relationships and high-margin revenue streams, the completion of this transaction remains contingent on due diligence and board approvals.\nWGRX Price Action: Wellgistics Health shares were up 21.60% at $0.13 during regular trading hours on Friday, according to Benzinga Pro.\nImage via Shutterstock\nTo add Benzinga News as your preferred source on Google, click here.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2626211261","isCrawlerRequest":true}